A low postoperative nonstimulated serum thyroglobulin level does not exclude the presence of radioactive iodine avid metastatic foci in intermediate-risk differentiated …
E Robenshtok, RK Grewal, S Fish, M Sabra, RM Tuttle - Thyroid, 2013 - liebertpub.com
Background: Postsurgical thyrotropin (TSH)-stimulated serum thyroglobulin (Tg) level can be
used to predict the likelihood of finding radioactive iodine (RAI) avid metastatic foci on …
used to predict the likelihood of finding radioactive iodine (RAI) avid metastatic foci on …
Postoperative Thyroglobulin and Neck Ultrasound in the Risk Restratification and Decision to Perform 131I Ablation
Context: There is much debate surrounding the choice of which patient should be submitted
to postsurgical remnant radioiodine remnant ablation (RRA), particularly in low-risk (LR) and …
to postsurgical remnant radioiodine remnant ablation (RRA), particularly in low-risk (LR) and …
[HTML][HTML] Undetectable or low (< 1 ng/ml) postsurgical thyroglobulin values do not rule out metastases in early stage differentiated thyroid cancer patients
A Campennì, L Giovanella, SA Pignata, A Vento… - Oncotarget, 2018 - ncbi.nlm.nih.gov
Background Differentiated thyroid cancer (DTC) work-up is based on (near) total-
thyroidectomy plus thyroid remnant ablation (TRA) with 131-radioiodine in many patients …
thyroidectomy plus thyroid remnant ablation (TRA) with 131-radioiodine in many patients …
Ongoing risk stratification for differentiated thyroid cancer (DTC)—stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of …
J Krajewska, M Jarząb, A Czarniecka… - Endokrynologia …, 2016 - journals.viamedica.pl
Introduction: Adequate postoperative risk assessment currently constitutes the principle of
DTC treatment and further management. The aim of the study—a retrospective assessment …
DTC treatment and further management. The aim of the study—a retrospective assessment …
A low postoperative nonstimulated serum thyroglobulin level excludes the presence of persistent disease in low‐risk papillary thyroid cancer patients: implication for …
PW Rosario, GF Mourão, TL Siman… - Clinical …, 2015 - Wiley Online Library
Objective To evaluate the presence of persistent disease, including on post‐therapy whole‐
body scan (Rx WBS), in low‐risk patients with papillary thyroid carcinoma (PTC)> 1 cm who …
body scan (Rx WBS), in low‐risk patients with papillary thyroid carcinoma (PTC)> 1 cm who …
Is there a role for diagnostic scans in the management of intermediate-risk thyroid cancer?
DLS Danilovic, GB Coura-Filho… - Endocrine-Related …, 2022 - erc.bioscientifica.com
Radioiodine (RAI) is selectively recommended for intermediate-risk differentiated thyroid
carcinomas (DTC). The information gleaned from pretherapy stimulated thyroglobulin levels …
carcinomas (DTC). The information gleaned from pretherapy stimulated thyroglobulin levels …
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin …
C Durante, T Montesano, M Attard… - The Journal of …, 2012 - academic.oup.com
Abstract Context: Serum thyroglobulin (Tg) assays are considered fundamental in
postoperative surveillance of differentiated thyroid cancer (DTC) patients. However, the …
postoperative surveillance of differentiated thyroid cancer (DTC) patients. However, the …
99mTc-pertechnetate scintigraphy predicts successful postoperative ablation in differentiated thyroid carcinoma patients treated with low radioiodine activities
L Giovanella, G Paone, T Ruberto… - Endocrinology and …, 2019 - synapse.koreamed.org
Background Postoperative routine radioiodine (RAI) treatment is currently debated for
patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low …
patients with low-risk differentiated thyroid carcinoma (DTC) patients. If performed, a low …
Persistent disease and recurrence in differentiated thyroid cancer patients with undetectable postoperative stimulated thyroglobulin level
C Nascimento, I Borget, A Al Ghuzlan… - Endocrine-Related …, 2011 - erc.bioscientifica.com
131 I is given in differentiated thyroid cancer (DTC) without taking into account thyroglobulin
(Tg) levels at the time of ablation, whereas 6–18 months later it is a major criterion for cure …
(Tg) levels at the time of ablation, whereas 6–18 months later it is a major criterion for cure …
Value of diagnostic radioiodine whole-body scanning after initial therapy in patients with differentiated thyroid cancer at intermediate and high risk for recurrence
PW Rosario, MS Furtado, AFCM Filho, RX Lacerda… - Thyroid, 2012 - liebertpub.com
Background: Diagnostic radioiodine whole-body scanning (DxWBS) in combination with
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …
stimulated thyroglobulin (Tg)(ie, measurement after levothyroxine [L-T4] withdrawal or …